PT Bundamedik Tbk (ISX:BMHS) ROC %: 1.21% (As of Mar. 2026)


ISX:BMHS PT Bundamedik Tbk ISX:BMHS
61 GF Score
Price Rp182.00
GF Value Rp304.24
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PT Bundamedik Tbk ROC %?

PT Bundamedik Tbk ISX:BMHS +1.11% 61 ROC % is 1.21% as of Mar. 2026. GuruFocus rates ISX:BMHS with a GF Score™ of 61/100 and a GF Value™ of Rp304.24 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. PT Bundamedik Tbk's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 1.21%.

As of today (2026-06-28), PT Bundamedik Tbk's WACC % is 4.21%. PT Bundamedik Tbk's ROC % is 1.67% (calculated using TTM income statement data). PT Bundamedik Tbk earns returns that do not match up to its cost of capital. It will destroy value as it grows.


PT Bundamedik Tbk  (ISX:BMHS) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, PT Bundamedik Tbk's WACC % is 4.21%. PT Bundamedik Tbk's ROC % is 1.67% (calculated using TTM income statement data). PT Bundamedik Tbk earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


PT Bundamedik Tbk ROC % Related Terms


PT Bundamedik Tbk ROC % Historical Data

* Premium members only.

The historical data trend for PT Bundamedik Tbk's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Bundamedik Tbk ROC % Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC %
Get a 7-Day Free Trial 18.28 6.61 1.31 1.46 1.82

PT Bundamedik Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.77 1.24 2.85 1.78 1.21
ISX:BMHS
61GF Score
PT Bundamedik Tbk ISX:BMHS
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Bundamedik Tbk ROC % Calculation

PT Bundamedik Tbk's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=93571.595 * ( 1 - 34.47% )/( (3092631.912 + 3646198.729)/ 2 )
=61317.4662035/3369415.3205
=1.82 %

where

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3446360.904 - 54606.094 - ( 299122.898 - max(0, 568415.968 - 1088880.786+299122.898))
=3092631.912

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4016429.435 - 124135.809 - ( 246094.897 - max(0, 746084.871 - 1210239.116+246094.897))
=3646198.729

PT Bundamedik Tbk's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=59290.872 * ( 1 - 25.43% )/( (3646198.729 + 3633495.261)/ 2 )
=44213.2032504/3639846.995
=1.21 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4016429.435 - 124135.809 - ( 246094.897 - max(0, 746084.871 - 1210239.116+246094.897))
=3646198.729

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4042907.843 - 125475.577 - ( 283937.005 - max(0, 721025.346 - 1224556.467+283937.005))
=3633495.261

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 1.21% mean?
PT Bundamedik Tbk (ISX:BMHS) has a ROC % of 1.21% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on PT Bundamedik Tbk and its competitors.
Is PT Bundamedik Tbk's ROC % too high?
PT Bundamedik Tbk's current ROC % is 1.21%. The Healthcare Providers & Services industry median ROC % is 3.08. PT Bundamedik Tbk's value of 1.21% is 60.7% below this industry median. Overall, PT Bundamedik Tbk has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's ROC % compare to HCA and THC?
PT Bundamedik Tbk's ROC % of 1.21% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROC % is 3.08. PT Bundamedik Tbk's value of 1.21% is 60.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Healthcare Providers & Services company?
The median ROC % among Healthcare Providers & Services companies is 3.08, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Bundamedik Tbk's current ROC % of 1.21% is 60.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on PT Bundamedik Tbk and its competitors. For the Healthcare Providers & Services industry, the median ROC % is 3.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Bundamedik Tbk's current ROC % is 1.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp304.24, compared to a current price of Rp182.00 — trading 40.2% below its estimated fair value. The current ROC % is 1.21% and 60.7% below the Healthcare Providers & Services industry median of 3.08. PT Bundamedik Tbk's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current ROC % is 1.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued. The current stock price of Rp182.00 is trading 40.2% below its estimated GF Value™ of Rp304.24. GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.

Key valuation signals for ISX:BMHS:

  • ROC %: 1.21%
  • GF Value™: Rp304.24 vs. price of Rp182.00 (40.2% below fair value)
  • GF Score™: 61/100 with 4 warning signs
  • Industry Position: 60.7% below the Healthcare Providers & Services median

No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Bundamedik Tbk Business Description

Address Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
61GF Score

Get the complete analysis for ISX:BMHS

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp182.00
Price
Rp304.24
GF Value